Publications by authors named "Soeren Fast"

Claim this Profile
T
The role of radioiodine therapy in benign nodular goitre.
Steen Joop Bonnema, Søren Fast, Laszlo Hegedüs

Best Pract Res Clin Endocrinol Metab· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prestimulation with recombinant human thyrotropin (rhTSH) improves the long-term outcome of radioiodine therapy for multinodular nontoxic goiter.
Søren Fast, Viveque Egsgaard Nielsen, Peter Grupe, Henrik Boel-Jørgensen, Lars Bastholt

J Clin Endocrinol Metab· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Icatibant is a new treatment option in life-threatening angioedema triggered by angiotensin-converting enzyme inhibitor].
Søren Fast, Emil Henningsen, Anette Bygum

Ugeskr Laeger· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radioiodine therapy of benign non-toxic goitre. Potential role of recombinant human TSH.
S Fast, S J Bonnema, L Hegedüs

Ann Endocrinol (Paris)· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant human thyrotropin-stimulated radioiodine therapy of nodular goiter allows major reduction of the radiation burden with retained efficacy.
Søren Fast, Laszlo Hegedüs, Peter Grupe, Viveque Egsgaard Nielsen, Christa Bluhme

J Clin Endocrinol Metab· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose-dependent acute effects of recombinant human TSH (rhTSH) on thyroid size and function: comparison of 0.1, 0.3 and 0.9 mg of rhTSH.
Søren Fast, Viveque E Nielsen, Steen J Bonnema, Laszlo Hegedüs

Clin Endocrinol (Oxf)· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing 131I uptake after rhTSH stimulation in patients with nontoxic multinodular goiter: evidence from a prospective, randomized, double-blind study.
Søren Fast, Viveque Egsgaard Nielsen, Peter Grupe, Steen Joop Bonnema, Laszlo Hegedüs

J Nucl Med· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time to reconsider nonsurgical therapy of benign non-toxic multinodular goitre: focus on recombinant human TSH augmented radioiodine therapy.
Søren Fast, Viveque Egsgaard Nielsen, Steen Joop Bonnema, Laszlo Hegedüs

Eur J Endocrinol· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The majority of Danish nontoxic goitre patients are ineligible for Levothyroxine suppressive therapy.
Søren Fast, Steen Joop Bonnema, Laszlo Hegedüs

Clin Endocrinol (Oxf)· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis